Andrea Arrossi, MD
- Call 216.444.9120
Specialty in Diseases & Conditions
- Interstitial Lung Disease (ILD)
- Mesothelioma
- Rare Cancer and Blood Disease Program
- Thymic Cancer
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Andrea Arrossi, MD
Andrea Arrossi, MD, is an Anatomic Pathology board-certified pathologist and a Staff member of the Pulmonary Pathology subspecialty service of the Department of Pathology at Cleveland Clinic. She is Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine and a past President of the Cleveland Society of Pathologists.
Dr. Arrossi joined Cleveland Clinic in 2006. Her clinical areas of expertise include pulmonary/thoracic and general surgical pathology. Dr. Arrossi has coauthored over 50 publications and 4 book chapters, and has given presentations at local, National and International meetings.
Originally from Argentina, Dr. Arrossi completed her medical school training in 1994 at Universidad de Buenos Aires, Argentina. She fulfilled her Anatomic Pathology residency at the Hospital de Clinicas, Universidad de Buenos Aires in Argentina in 1998 and a surgical pathology fellowship at the Instituto de Oncologia Angel Roffo in 1999. Subsequently, Dr. Arrossi completed her second residency program in Anatomic Pathology at Cleveland Clinic in 2005. Her first hospital appointment was Staff Pathologist at Instituto Papanicolau in Buenos Aires, Argentina, and Hospital Municipal Dr. Bernardo Houssay and associated Hospital Zonal del Tórax “Dr. Antonio Cetrángolo”, Buenos Aires, Argentina in 1999.
Dr. Arrossi was recognized with the 2005 Rodger C. Haggitt Gastrointestinal Pathology Society Award (Runner Up) for research conducted at Cleveland Clinic on “Backwash Ileitis in Total Proctocolectomy Specimens in Patients Treated with Ileal Pouch Anal Anastomosis”. She was previously part of the research team of the Instituto Papanicolau in Buenos Aires, Argentina, recognized with the Florencio Fiorini Annual Merit Award for the work conducted on “Viral Typification for Screening in Cervical Cancer” in September 2000. Dr. Arrossi was also recognized with the “Robert J Tomsich Pathology and Laboratory Medicine Institute Center for Pathology Education CCLCM Teaching Award” at the Cleveland Clinic in 2018
Education & Professional Highlights
Appointed
2006
Education & Fellowships
Fellowship - University of Texas M.D. Anderson Cancer Center
Surgical Pathology
Houston,
TX United States
2006
Residency - Cleveland Clinic
Anatomic Pathology
Cleveland,
OH
2005
Medical Education - Facultad de Medicina, Universidad de Buenos Aires
MD
Argentina
1995
Additional Training
Professional Highlights
Certifications
- Pathology - Anatomic Pathology
Specialty Interests
Pulmonary pathology, Pathology of the Mediastinum, Thymic Pathology, Mesothelioma
Awards & Honors
Innovations & Patents
Memberships
- United States and Canadian Academy of Pathology
- Pulmonary Pathology Society
- International Thymic Malignancies Interest Group
Research & Publications
See publications for Andrea Arrossi, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/18/2024, Dr. Arrossi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
